BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4354694)

  • 21. Antiviral effect of trimeric 2',5'-oligoadenylic acid and some of its analogues.
    Tkachuk ZYu ; Semernikova LI; Tkachuk VV; Reshot'ko LM; Tkachuk LV; Eremenko T; Matsuka GK; Mikhailopulo IA
    New Microbiol; 1998 Apr; 21(2):141-6. PubMed ID: 9579338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral activity of substituted 6-methylmercaptopyrazolo(3,4-d)pyrimidines and their ribosides.
    Bektemirov TA; Chekunova EV; Korbukh IA; Bulychev YuN ; Yakunina NG; Preobrazhenskaya MN
    Acta Virol; 1981 Sep; 25(5):326-9. PubMed ID: 6118054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicity of 9-beta-D-arabinofuranosyladenine in mice and rabbits.
    Kurtz SM; Fisken RA; Kaump DH; Schardn JL
    Antimicrob Agents Chemother (Bethesda); 1968; 8():180-9. PubMed ID: 5735360
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-herpes activity of the adenine arabinoside analog, 2'-azido-2'-deoxy-beta-D-arabinofuranosyladenine.
    Cermak-Mörth CM; Christian R; Unger FM
    Biochem Pharmacol; 1979 Jul; 28(13):2105-8. PubMed ID: 224885
    [No Abstract]   [Full Text] [Related]  

  • 25. The antiviral activity of 9-beta-D-arabinofuranosyladenine is enhanced by the 2',3'-dideoxyriboside, the 2',3'-didehydro-2',3'-dideoxyriboside and the 3'-azido-2',3'-dideoxyriboside of 2,6-diaminopurine.
    Balzarini J; De Clercq E
    Biochem Biophys Res Commun; 1989 Feb; 159(1):61-7. PubMed ID: 2538128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiviral effect of acridine derivative C 283].
    Szulc K
    Med Dosw Mikrobiol; 1976; 28(1):57-64. PubMed ID: 176540
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of four antiviral agents in the treatment of herpes simplex encephalitis in a rat model.
    Marks MI
    J Infect Dis; 1975 Jan; 131(1):11-6. PubMed ID: 162922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral activity of a pyrazino-pyrazine derivative.
    Verini MA; Fioretti A; Casazza AM; Sanfilippo A; Palamidessi G; Ghione M
    Chemotherapy; 1975; 21(3-4):221-30. PubMed ID: 169110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (S)-9-(2,3-Dihydroxypropyl)adenine: an aliphatic nucleoside analog with broad-spectrum antiviral activity.
    De Clercq E; Descamps J; De Somer P; Holý A
    Science; 1978 May; 200(4341):. PubMed ID: 205946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleic acids. 3. Antiviral activity of nucleotides and dinucleoside phosphates containing ara-cytidine.
    Renis HE; Hollowell CA; Underwood GE
    J Med Chem; 1967 Sep; 10(5):777-82. PubMed ID: 4292736
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of acyclovir-resistant herpes simplex and varicella zoster virus infections.
    Safrin S
    Adv Exp Med Biol; 1996; 394():59-66. PubMed ID: 8815710
    [No Abstract]   [Full Text] [Related]  

  • 32. Helicase-primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infections.
    Biswas S; Sukla S; Field HJ
    Future Med Chem; 2014 Jan; 6(1):45-55. PubMed ID: 24358947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral compounds. XIV.
    Massarani E; Nardi D; Palmeri C; Degen L; Altucci P; Catalano G; Varone GL
    Arzneimittelforschung; 1973 Apr; 23(4):573-5. PubMed ID: 4740237
    [No Abstract]   [Full Text] [Related]  

  • 34. Improved synthesis and in vitro antiviral activities of 5-cyanouridine and 5-cyano-2'-deoxyuridine.
    Torrence PF; Bhooshan B
    J Med Chem; 1977 Jul; 20(7):974-6. PubMed ID: 195058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of acyl substituents of synthetic lipid A-subunit analogues on their immunomodulating antiviral activity.
    Ikeda S; Nishimura C; Matsuura M; Homma JY; Kiso M; Hasegawa A
    Antiviral Res; 1990 Jun; 13(6):327-33. PubMed ID: 1699495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral agents: synthesis of furylpyrimidinones and evaluation of their cytostatic and antiviral activity.
    Botta M; De Angelis F; Corelli F; Menichincheri M; Nicoletti R; Marongiu ME; Pani A; La Colla P
    Arch Pharm (Weinheim); 1991 Apr; 324(4):203-7. PubMed ID: 1650546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches.
    de Clercq E
    Ann Ist Super Sanita; 1987; 23(4):841-7. PubMed ID: 2837935
    [No Abstract]   [Full Text] [Related]  

  • 38. Antiviral activity of carbopol, a cross-linked polycarboxylate.
    de Clercq E; Luczak M
    Arch Virol; 1976; 52(1-2):151-8. PubMed ID: 187146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of herpes simplex virus by a pregnene derivative (TX 3047).
    Perbal B
    Br J Pharmacol; 1981 Apr; 72(4):597-602. PubMed ID: 6269678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evaluation of certain chain-extended analogues of 9-beta-D-arabinofuranosyladenine for antiviral and cardiovascular activity.
    Baker DC; Crews RP; Haskell TH; Putt SR; Arnett G; Shannon WM; Reinke CM; Katlama NB; Drach JC
    J Med Chem; 1983 Oct; 26(10):1530-4. PubMed ID: 6312045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.